REFERENCES
1. Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133:155217.
2. Du W, Wang H, Su C, Jia X, Zhang B. Thirty-year urbanization trajectories and obesity in modernizing China. Int J Environ Res Public Health. 2022;19:1943.
3. 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405:813-38.
4. Olm M, Stark RG, Beck N, Röger C, Leidl R. Impact of interventions to reduce overnutrition on healthcare costs related to obesity and type 2 diabetes: a systematic review. Nutr Rev. 2020;78:412-35.
5. Choo YN, Ravi RN, Subramaniyan V. Insulin resistance induced by obesity: Mechanisms, metabolic implications and therapeutic approaches. Mol Biol Rep. 2026;53:357.
6. Zatterale F, Longo M, Naderi J, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2019;10:1607.
7. Sancar G, Birkenfeld AL. The role of adipose tissue dysfunction in hepatic insulin resistance and T2D. J Endocrinol. 2024;262:e240115.
8. Kochumon S, Malik MZ, Sindhu S, et al. Gut dysbiosis shaped by cocoa butter-based sucrose-free HFD leads to steatohepatitis, and insulin resistance in mice. Nutrients. 2024;16:1929.
9. Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315.
10. Takeuchi N, Higashida K, Li X, Nakai N. Glucose enhances catecholamine-stimulated lipolysis via increased glycerol-3-phosphate synthesis in 3T3-L1 adipocytes and rat adipose tissue. Mol Biol Rep. 2021;48:6269-76.
11. Palacios-Ortega S, Varela-Guruceaga M, Martínez JA, de Miguel C, Milagro FI. Effects of high glucose on caveolin-1 and insulin signaling in 3T3-L1 adipocytes. Adipocyte. 2016;5:65-80.
12. Rharass T, Lucas S. High glucose level impairs human mature bone marrow adipocyte function through increased ROS production. Front Endocrinol. 2019;10:607.
13. Tang L, Huang X, Li P. High glucose triggers macrophage senescence through mitochondrial dysfunction and mitophagy impairment. Cell Biochem Funct. 2026;44:e70211.
14. Świderska E, Podolska M, Strycharz J, et al. Hyperglycemia changes expression of key adipogenesis markers (C/EBPα and PPARy) and morphology of differentiating human visceral adipocytes. Nutrients. 2019;11:1835.
15. Jiang N, Yang M, Han Y, Zhao H, Sun L. PRDM16 regulating adipocyte transformation and thermogenesis: a promising therapeutic target for obesity and diabetes. Front Pharmacol. 2022;13:870250.
16. Delcourt M, Tagliatti V, Delsinne V, Colet JM, Declèves AE. Influence of nutritional intake of carbohydrates on mitochondrial structure, dynamics, and functions during adipogenesis. Nutrients. 2020;12:2984.
17. Achari AE, Jain SK. L-Cysteine supplementation increases adiponectin synthesis and secretion, and GLUT4 and glucose utilization by upregulating disulfide bond A-like protein expression mediated by MCP-1 inhibition in 3T3-L1 adipocytes exposed to high glucose. Mol Cell Biochem. 2016;414:105-13.
18. Tsuchiya A, Nagaya H, Kanno T, Nishizaki T. Oleic acid stimulates glucose uptake into adipocytes by enhancing insulin receptor signaling. J Pharmacol Sci. 2014;126:337-43.
19. Jiang S, Zhang G, Miao J, et al. Transcriptome and metabolome analyses provide insight into the glucose-induced adipogenesis in porcine adipocytes. Curr Issues Mol Biol. 2024;46:2027-42.
20. Qiao Q, Bouwman FG, Renes J, Mariman ECM. An in vitro model for hypertrophic adipocytes: time-dependent adipocyte proteome and secretome changes under high glucose and high insulin conditions. J Cell Mol Med. 2020;24:8662-73.
21. Cao Y, Zhao R, Guo K, et al. Potential metabolite biomarkers for early detection of stage-I pancreatic ductal adenocarcinoma. Front Oncol. 2021;11:744667.
22. Huang S, Liang H, Chen Y, et al. Hypoxanthine ameliorates diet-induced insulin resistance by improving hepatic lipid metabolism and gluconeogenesis via AMPK/mTOR/PPARα pathway. Life Sci. 2024;357:123096.
23. Ye J, Bi X, Deng S, et al. Hypoxanthine is a metabolic biomarker for inducing GSDME-dependent pyroptosis of endothelial cells during ischemic stroke. Theranostics. 2024;14:6071-87.
24. Toledo-Ibelles P, Gutiérrez-Vidal R, Calixto-Tlacomulco S, Delgado-Coello B, Mas-Oliva J. Hepatic accumulation of hypoxanthine: a link between hyperuricemia and nonalcoholic fatty liver disease. Arch Med Res. 2021;52:692-702.
